Literature DB >> 11029364

Sleep-disordered respiration in phenotypically normotensive, genetically hypertensive rats.

D W Carley1, K Berecek, A Videnovic, M Radulovacki.   

Abstract

Increased prevalence of sleep-related breathing disorders has been reported in patients with essential hypertension and we have described disordered breathing in spontaneously hypertensive rats, an animal model of genetic hypertension. The mechanisms coupling hypertension to respiratory dysfunction during sleep remain, however, largely unknown. To determine if sleep-related respiratory disorder reflects cardiovascular derangement or, alternatively, represents an independent phenotype in hypertensive rats, we polygraphically recorded groups (n = 10) of genetically hypertensive, genetically normotensive, and phenotypically normotensive rats carrying a genetic background for hypertension. Apnea index was elevated more than 15-fold during NREM sleep in both animal groups carrying hypertension-related genes (p < 0.0001 for each) versus normotensive Wistar Kyoto rats. During REM sleep, a genetic background for hypertension was associated with an increased apnea index of at least 500% versus normotensive Wistar Kyoto rats (p < 0.0001 for each comparison). Still, overall mean respiratory rate, minute ventilation, and sleep architecture were equivalent among all animal groups. As expected, blood pressure and heart period were similar in both normotensive groups but elevated in the hypertensive animals. Persistent sleep-related breathing disorder despite effective cardiovascular normalization in the phenotypically normotensive but genetically hypertensive rats suggests that disordered breathing represents a genetically determined phenotype in these animals that is not secondary to the cardiovascular derangements. The model system described here may provide a powerful tool for investigation of the determinants of sleep-related breathing disorder.

Entities:  

Mesh:

Year:  2000        PMID: 11029364     DOI: 10.1164/ajrccm.162.4.9911033

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Acute exacerbation of sleep apnea by hyperoxia impairs cognitive flexibility in Brown-Norway rats.

Authors:  Irina Topchiy; Dionisio A Amodeo; Michael E Ragozzino; Jonathan Waxman; Miodrag Radulovacki; David W Carley
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

Review 2.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

3.  Effects of orexin 2 receptor activation on apnea in the C57BL/6J mouse.

Authors:  Michael W Moore; Afaf Akladious; Yufen Hu; Sausan Azzam; Pingfu Feng; Kingman P Strohl
Journal:  Respir Physiol Neurobiol       Date:  2014-06-11       Impact factor: 1.931

Review 4.  Cardiovascular consequences of sleep apnea.

Authors:  Saeid Golbidi; Mohammad Badran; Najib Ayas; Ismail Laher
Journal:  Lung       Date:  2011-11-03       Impact factor: 2.584

Review 5.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Brown Norway and Zucker Lean rats demonstrate circadian variation in ventilation and sleep apnea.

Authors:  Anne M Fink; Irina Topchiy; Michael Ragozzino; Dionisio A Amodeo; Jonathan A Waxman; Miodrag G Radulovacki; David W Carley
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

7.  Surges of arterial pressure during REM sleep in spontaneously hypertensive rats.

Authors:  Chiara Berteotti; Carlo Franzini; Pierluigi Lenzi; Giovanna Zoccoli; Alessandro Silvani
Journal:  Sleep       Date:  2008-01       Impact factor: 5.849

Review 8.  Rodent models of sleep apnea.

Authors:  Eric M Davis; Christopher P O'Donnell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-27       Impact factor: 1.931

Review 9.  The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.

Authors:  Lucilia N Diogo; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.